Author: PRISMWebmaster

Retaining top talent and supporting the career development of your employees go hand in hand. As a manager, HR leader, or company head, making career development palpable for those around you can feel unreachable. K.C. McAllister discusses career development and feedback strategies with industry expert Amanda Lopez on today’s episode. Amanda Lopez is the Executive Director for Talent Management & HRBP at Entrada Therapeutics, a growing biopharmaceutical company innovating to transform the treatment of devastating diseases through intracellular therapeutics.

There’s a LOT more to the pharmacy industry than your local corner store! Today’s guest is Jessica Smith, a Infectious Disease Pharmacist at a large academic medical center, sharing her epiphany about the diversity within pharmacy and where her career has taken her. One of our very own recruiters, Drew Leininger, conducts the interview.

Everyone’s life science career is full of twists and turns, but Sweta Girgenrath’s journey is particularly winding. From the lab to the classroom and back again, not to mention traveling halfway across the world to settle in the US, Girgenrath recounts her career until now and what the future holds with May Li, Mix Talent’s R&D Recruiting Team Lead. Sweta Girgenrath holds over 15 years of experience spanning academia and pharmaceutical industry working at the interface of the complex pathophysiology of rare and ultra-rare muscle / cardiac disease and therapy development.

The Life Sciences never sounded so good, especially in Ohio! With major cities like Columbus, Cleveland and Cincinnati on an upward trajectory, all facets of the medical industry continue to expand. Today, KC McAlister sits down in our headquarters hometown of Columbus to get an update from our friends at BioOhio. She is joined by BioOhio’s President, CEO and former guest Eddie Pauline as well as Board Vice-Chair Michael Triplett.

BioOhio advances the state’s bioscience, health, and life sciences industries, convening dynamic companies, people, and institutions to elevate the ecosystem in Ohio while supporting those that drive health, economic, and social well-being in communities across the globe.

In the modern era of work, companies understand many of the physical needs of their employees…but what about emotional? How can organizations cultivate positive workplace attitudes through HR? Mix Talent’s Paige Nelson uncovers some solutions when she sits down with Ashley Herd in today’s episode. Ashley Herd is the Founder and CEO of The Manager Method, where she helps upskill individuals in their career goals, managers in becoming people leaders, and organizations in their enterprise-wide needs.

The path to a groundbreaking career in the life sciences may not be so straight! Sometimes a strong mentor and a personal mission can make all the difference. Deniz Razon’s journey to Board Member of Servier Pharmaceuticals reflects just that when she talks to Mix Talent’s Todd Radloff in today’s episode. Razon also functions as the Chief Business Officer of Servier Pharmaceuticals, a privately held company that’s a growing leader in oncology.

In the US, a majority of people only see a doctor for a yearly check up. How do you address chronic medical conditions with such a “one and done” mindset? Erica Conroy and her work with the company AndHealth tackles that exact struggle. Mix Talent’s K.C. McAllister sits down with Conroy on this week’s episode. Conroy is the Senior Vice President of Employer Partnership at AndHealth, the leading digital health solution for autoimmune diseases and migraine. Employers use AndHealth’s disease reversal programs to unlock employee engagement and productivity while reducing healthcare costs.

The Gene and Cell Therapy industry continues to grow, and with growth comes many brilliantly led startups, filled with wisdom on business management and therapeutic science. With her third appearance as Mix Tape interviewer, Patty Adams talks with Rich Daly, President of CARSgen Therapeutics. CARSgen Therapeutics is a pharmaceutical company focused on innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors, with a vision to make cancer curable.